Explore the Recent Research Into the Global Type 2 Diabetes: By

"The Report Global Type 2 Diabetes Market 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -”


Albany, NY -- (SBWIRE) -- 04/04/2016 -- About Type 2 Diabetes
Diabetes, often referred to as diabetes mellitus, is a metabolic disease in which the patients' blood glucose levels remains high. Depending on the cause of development of diabetes, it can be divided into three types:

Type 1 diabetes (or insulin-dependent diabetes mellitus): In this condition, the pancreas do not produce the required amount of insulin, leading to high blood glucose levels.

Type 2 diabetes (non-insulin dependent diabetes mellitus): In this condition, though the body produces the required amount of insulin, the cells do not respond to it, increasing the glucose levels in the body.

Gestational diabetes: This condition occurs in pregnant women without any prior history of diabetes

Type 2 diabetes, also known as adult-onset diabetes, is a result of the body's inability to produce enough insulin or insulin resistance or both. It is managed by providing symptomatic relief and improving the quality of life. Type 2 diabetes accounts for nearly 90%-95% of the total number of diabetes cases worldwide and is primarily diagnosed in the middle-aged and old age groups, i.e., between the ages of 30 and 75 years. However, it can occur even during childhood. The risks of type 2 diabetes include high blood pressure, advancing age, obesity, history of gestational diabetes, family history of diabetes, poor nutrition during pregnancy, physical inactivity, and impaired glucose tolerance.

View Full Report at:

Technavios analysts forecast the Global Type 2 Diabetes Drugs Market to grow at a CAGR of 7.28% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global type 2 diabetes drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat type 2 diabetes.

The market is divided into the following segments based on geography:


Technavio's report, Global Type 2 Diabetes Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Detail Report With Complete TOC at:

Key vendors

AstraZeneca plc
Eli Lilly and Company
Merck & Co. Inc.
Novo Nordisk A/S
Sanofi SA

Other prominent vendors

Akros Pharma
Astellas Pharma
Boehringer Ingelheim
Chipscreen Biosciences
CymaBay Therapeutics
Daiichi Sankyo
Diasome Pharmaceuticals
Dong-A ST
Elcelyx Therapeutics
Hua Medicine
InteKrin Therapeutics
Ionis Pharmaceuticals
Janssen Pharmaceuticals
Japan Tobacco
KinDex Pharmaceuticals
Kotobuki Pharmaceutical
Lexicon Pharmaceuticals
Melior Pharmaceuticals
Metabolic Solutions Development Company
Mitsubishi Tanabe Pharma
NuSirt Biopharma
Sanwa Kagaku Kenkyusho
Sirona Biochem
Transition Therapeutics
vTv Therapeutics

Market driver

Rising prevalence of diabetes
For a full, detailed list, view our report

Market challenge
Low diagnosis rate
For a full, detailed list, view our report

Market trend

Increase in awareness of diabetes
For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Browse More PressRelease:

About is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074